<DOC>
	<DOCNO>NCT00981097</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . PURPOSE : This research study look blood tissue sample patient aggressive non-Hodgkin B-cell lymphoma Hodgkin lymphoma .</brief_summary>
	<brief_title>Study Blood Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma Hodgkin Lymphoma</brief_title>
	<detailed_description>OBJECTIVES : Primary - To estimate proportion patient diffuse large B-cell/immunoblastic Burkitt histology elevate serum free light chain ( FLC ) . - To estimate proportion patient Hodgkin lymphoma clonal immunoglobulin ( Ig ) DNA detection plasma . Secondary - To estimate agreement detection monoclonal Ig DNA spike plasma detection monoclonal DNA spike tumor tissue . - To estimate agreement fragment length spike tumor tissue fragment length spike plasma . - To estimate detection rate elevate FLC histology , include diffuse large B-cell/immunoblastic Burkitt lymphoma . - To estimate detection rate clonal Ig DNA histology , include diffuse large B-cell/immunoblastic , Burkitt lymphoma , Hodgkin lymphoma . - To analyze clinical pathologic correlate detection serum/plasma test : disease subtype , stage disease , disease bulk , lactate dehydrogenase , Ki-67 index . - To estimate detection rate clonotypic B-cells peripheral blood mononuclear cell patient Hodgkin lymphoma . OUTLINE : This multicenter study . Blood tissue sample collect time diagnosis analyze serum free light chain clonal immunoglobulin ( Ig ) DNA rearrangement circulate clonotypic B-cells via PCR . PROJECTED ACCRUAL : A total 50 patient ( 25 diffuse large B-cell/immunoblastic histology , 15 Burkitt lymphoma , 10 Hodgkin lymphoma ) accrue study .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis untreated aggressive Bcell lymphoma , include : Diffuse large B cell/immunoblastic lymphoma Burkitt lymphoma Hodgkin lymphoma Serological documentation HIV infection FDAapproved test Available diagnostic material fresh frozen tissue formalinfixed paraffin embed tissue OR willing undergo repeat biopsy ( fine needle aspiration acceptable ) PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>HIV infection</keyword>
	<keyword>HIV-associated Hodgkin lymphoma</keyword>
	<keyword>stage I adult Hodgkin lymphoma</keyword>
	<keyword>stage II adult Hodgkin lymphoma</keyword>
	<keyword>stage III adult Hodgkin lymphoma</keyword>
	<keyword>stage IV adult Hodgkin lymphoma</keyword>
	<keyword>contiguous stage II adult Burkitt lymphoma</keyword>
	<keyword>noncontiguous stage II adult Burkitt lymphoma</keyword>
	<keyword>stage I adult Burkitt lymphoma</keyword>
	<keyword>stage III adult Burkitt lymphoma</keyword>
	<keyword>stage IV adult Burkitt lymphoma</keyword>
	<keyword>contiguous stage II adult diffuse large cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult diffuse large cell lymphoma</keyword>
	<keyword>stage I adult diffuse large cell lymphoma</keyword>
	<keyword>stage III adult diffuse large cell lymphoma</keyword>
	<keyword>stage IV adult diffuse large cell lymphoma</keyword>
	<keyword>contiguous stage II adult immunoblastic large cell lymphoma</keyword>
	<keyword>noncontiguous stage II adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage I adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage III adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage IV adult immunoblastic large cell lymphoma</keyword>
</DOC>